Prelude Capital Management, LLC Psychemedics Corp Transaction History

Prelude Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$4.63 - $10.62 $7,843 - $17,990	-1,694 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$8.7 - $9.79 $12,179 - $13,705	-1,400 Reduced 45.25%	1,694 $16,000
Q3 2019 Nov 14, 2019	SELL	$7.2 - $10.2 $16,538 - $23,429	-2,297 Reduced 42.61%	3,094 $28,000
Q2 2019 Aug 14, 2019	BUY	$9.5 - $14.5 $15,361 - $23,446	1,617 Added 42.85%	5,391 $54,000
Q1 2019 May 15, 2019	BUY	$13.83 - $19.63 $24,202 - $34,352	1,750 Added 86.46%	3,774 $53,000
Q4 2018 Feb 14, 2019	BUY	$14.15 - $18.99 $12,777 - $17,147	903 Added 80.55%	2,024 $32,000
Q3 2018 Nov 14, 2018	SELL	$18.7 - $21.72 $6,227 - $7,232	-333 Reduced 22.9%	1,121 $21,000
Q2 2018 Aug 14, 2018	SELL	$18.55 - $21.37 $12,057 - $13,890	-650 Reduced 30.89%	1,454 $28,000
Q1 2018 May 15, 2018	SELL	$19.52 - $22.64 $39,040 - $45,280	-2,000 Reduced 48.73%	2,104 $45,000
Q4 2017 Feb 14, 2018	SELL	$16.63 - $21.24 $2,860 - $3,653	-172 Reduced 4.02%	4,104 $84,000
Q3 2017 Nov 14, 2017	BUY	$17.43 - $21.51 $74,530 - $91,976	4,276	4,276 $79,000

1.19M

Ticker PMD
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 5,626,200
Market Cap $13.1M
Description
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.